Workflow
特朗普要签“最惠国”药价令,美国药价或将狂降30%至80%!
Jin Shi Shu Ju·2025-05-12 00:36

Group 1 - The core viewpoint of the news is that President Trump plans to sign an executive order to enforce a global minimum drug price in the U.S. to lower prescription drug costs [1] - Trump claims that U.S. citizens pay significantly higher prices for prescription drugs compared to other countries, sometimes five to ten times more for the same medication [1] - The implementation of the "most favored nation" policy is expected to align U.S. drug prices with those of countries with the lowest prices, potentially reducing U.S. drug costs by 30% to 80% [1] Group 2 - The Biden administration has initiated price negotiations for high-cost drugs used in Medicare under the Inflation Reduction Act, with plans to expand the scope annually [2] - Trump's previous attempts to implement a pricing plan for prescription drugs were halted by federal courts due to lawsuits from pharmaceutical companies, which claimed improper rule-making procedures [2] - The Biden administration shifted focus to legislative efforts, resulting in the passage of the Inflation Reduction Act after Trump's plan was blocked [2]